rs41277200

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 2P and 20B. PM1BP4_StrongBP6_Very_StrongBA1

The NM_206933.4(USH2A):​c.8656C>T​(p.Leu2886Phe) variant causes a missense change. The variant allele was found at a frequency of 0.049 in 1,613,538 control chromosomes in the GnomAD database, including 2,469 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. L2886P) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.050 ( 221 hom., cov: 32)
Exomes 𝑓: 0.049 ( 2248 hom. )

Consequence

USH2A
NM_206933.4 missense

Scores

1
17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:13

Conservation

PhyloP100: 6.84

Publications

30 publications found
Variant links:
Genes affected
USH2A (HGNC:12601): (usherin) This gene encodes a protein that contains laminin EGF motifs, a pentaxin domain, and many fibronectin type III motifs. The protein is found in the basement membrane, and may be important in development and homeostasis of the inner ear and retina. Mutations within this gene have been associated with Usher syndrome type IIa and retinitis pigmentosa. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2008]
USH2A Gene-Disease associations (from GenCC):
  • Usher syndrome type 2
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • Usher syndrome type 2A
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • retinitis pigmentosa 39
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • retinitis pigmentosa
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

PM1
In a hotspot region, there are 2 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 12 uncertain in NM_206933.4
BP4
Computational evidence support a benign effect (MetaRNN=0.0016551912).
BP6
Variant 1-215877783-G-A is Benign according to our data. Variant chr1-215877783-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 48607.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.134 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
USH2ANM_206933.4 linkc.8656C>T p.Leu2886Phe missense_variant Exon 43 of 72 ENST00000307340.8 NP_996816.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
USH2AENST00000307340.8 linkc.8656C>T p.Leu2886Phe missense_variant Exon 43 of 72 1 NM_206933.4 ENSP00000305941.3
USH2AENST00000674083.1 linkc.8656C>T p.Leu2886Phe missense_variant Exon 43 of 73 ENSP00000501296.1

Frequencies

GnomAD3 genomes
AF:
0.0496
AC:
7532
AN:
151996
Hom.:
222
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0588
Gnomad AMI
AF:
0.0187
Gnomad AMR
AF:
0.0632
Gnomad ASJ
AF:
0.0104
Gnomad EAS
AF:
0.142
Gnomad SAS
AF:
0.0758
Gnomad FIN
AF:
0.00605
Gnomad MID
AF:
0.0475
Gnomad NFE
AF:
0.0411
Gnomad OTH
AF:
0.0513
GnomAD2 exomes
AF:
0.0523
AC:
13130
AN:
251254
AF XY:
0.0516
show subpopulations
Gnomad AFR exome
AF:
0.0606
Gnomad AMR exome
AF:
0.0625
Gnomad ASJ exome
AF:
0.0100
Gnomad EAS exome
AF:
0.156
Gnomad FIN exome
AF:
0.00758
Gnomad NFE exome
AF:
0.0365
Gnomad OTH exome
AF:
0.0413
GnomAD4 exome
AF:
0.0489
AC:
71474
AN:
1461424
Hom.:
2248
Cov.:
32
AF XY:
0.0491
AC XY:
35702
AN XY:
727032
show subpopulations
African (AFR)
AF:
0.0593
AC:
1984
AN:
33464
American (AMR)
AF:
0.0622
AC:
2782
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.0106
AC:
276
AN:
26126
East Asian (EAS)
AF:
0.135
AC:
5347
AN:
39682
South Asian (SAS)
AF:
0.0787
AC:
6789
AN:
86254
European-Finnish (FIN)
AF:
0.00889
AC:
475
AN:
53404
Middle Eastern (MID)
AF:
0.0331
AC:
191
AN:
5766
European-Non Finnish (NFE)
AF:
0.0451
AC:
50167
AN:
1111638
Other (OTH)
AF:
0.0574
AC:
3463
AN:
60372
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.460
Heterozygous variant carriers
0
3806
7612
11417
15223
19029
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2082
4164
6246
8328
10410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0495
AC:
7532
AN:
152114
Hom.:
221
Cov.:
32
AF XY:
0.0501
AC XY:
3723
AN XY:
74360
show subpopulations
African (AFR)
AF:
0.0587
AC:
2437
AN:
41492
American (AMR)
AF:
0.0630
AC:
962
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
0.0104
AC:
36
AN:
3470
East Asian (EAS)
AF:
0.142
AC:
736
AN:
5178
South Asian (SAS)
AF:
0.0757
AC:
365
AN:
4822
European-Finnish (FIN)
AF:
0.00605
AC:
64
AN:
10584
Middle Eastern (MID)
AF:
0.0408
AC:
12
AN:
294
European-Non Finnish (NFE)
AF:
0.0411
AC:
2793
AN:
67990
Other (OTH)
AF:
0.0522
AC:
110
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
358
716
1074
1432
1790
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
92
184
276
368
460
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0446
Hom.:
620
Bravo
AF:
0.0527
TwinsUK
AF:
0.0488
AC:
181
ALSPAC
AF:
0.0410
AC:
158
ESP6500AA
AF:
0.0624
AC:
275
ESP6500EA
AF:
0.0381
AC:
328
ExAC
AF:
0.0520
AC:
6309
Asia WGS
AF:
0.103
AC:
359
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:13
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:5
Jul 22, 2016
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 16, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 19737284, 21569298, 25528277, 17085681, 18273898, 30245029) -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 29, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:4
Jun 24, 2009
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 10, 2021
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 15, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Usher syndrome type 2A Benign:2
Sep 16, 2020
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jul 01, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Usher syndrome type 2A;C3151138:Retinitis pigmentosa 39 Benign:1
Jan 04, 2022
Fulgent Genetics, Fulgent Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Retinal dystrophy Benign:1
Oct 01, 2023
Dept Of Ophthalmology, Nagoya University
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:research

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.037
BayesDel_addAF
Benign
-0.65
T
BayesDel_noAF
Benign
-0.57
CADD
Benign
20
DANN
Benign
0.48
DEOGEN2
Benign
0.062
T
Eigen
Benign
-0.54
Eigen_PC
Benign
-0.20
FATHMM_MKL
Benign
0.20
N
LIST_S2
Benign
0.26
T
MetaRNN
Benign
0.0017
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
-2.0
N
PhyloP100
6.8
PrimateAI
Uncertain
0.61
T
PROVEAN
Benign
2.5
N
REVEL
Benign
0.14
Sift
Benign
1.0
T
Sift4G
Benign
1.0
T
Polyphen
0.0
B
Vest4
0.065
MPC
0.031
ClinPred
0.0098
T
GERP RS
5.9
Varity_R
0.056
gMVP
0.12
Mutation Taster
=96/4
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41277200; hg19: chr1-216051125; COSMIC: COSV56343477; API